Sun, Dec 21, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Cantab Capital appoints Adam Glinsman as Managing Director

Monday, August 05, 2013
Opalesque Industry Update - Cantab Capital, the multi-billion systematic global macro manager has hired Adam Glinsman for the newly created position of Managing Partner.

Glinsman will formally take up the role at the start of September. He brings 25 years experience across the investment and capital markets industries. After a prior career in institutional equities, between 2003 and 2009 Adam was COO and Partner of Lansdowne Partners, one of the leading fundamental long/short equity firms, where he was a member of the Management Committee, with primary responsibility for Business Management and Development, and Enterprise Risk. After retiring from Lansdowne in 2009, amongst other initiatives Adam remained a consultant to the flagship Lansdowne Developed Markets Funds, as well as to Cambridge University in the evolution of its internal IP commercialisation strategy.

Glinsman will be working alongside the Founding Partner and CIO/CEO, Dr Ewan Kirk. Glinsman will concentrate on the management and evolution of all non-investment aspects of the business. Dr Kirk will maintain his focus on leading the investment research for Cantab.

Dr Kirk said: “We are really excited that Adam is joining us because of the decades of experience he brings and the value he will add to our business and investors. Importantly, he is culturally a good fit for a technology-driven financial firm like Cantab.”

Cantab Capital

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und